Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Expert Opinion on Drug Delivery|December 2, 2009
Receptor-mediated tumor targeting based on peptide hormonesGábor Mezo, Marilena ManeaExpert Opinion on Therapeutic Patents|November 27, 2009
Luteinizing hormone-releasing hormone antagonistsGábor Mezo, Marilena ManeaJournal of Peptide Science : an Official Publication of the European Peptide Society|March 31, 2007
Mass spectrometric identification of the trypsin cleavage pathway in lysyl-proline containing oligotuftsin peptidesMarilena Manea, Gábor Mezo, Ferenc Hudecz, et al.Current Medicinal Chemistry|October 16, 2008
New derivatives of GnRH as potential anticancer therapeutic agentsGábor Mezo, Marilena Manea, Ildikí Szabí, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|August 26, 2011
Anthracycline-GnRH derivative bioconjugates with different linkages: synthesis, in vitro drug release and cytostatic effectPascal Schlage, Gábor Mezo, Erika Orbán, et al.Anti-Cancer Drugs|September 15, 2011
In-vivo antitumour effect of daunorubicin-GnRH-III derivative conjugates on colon carcinoma-bearing miceMarilena Manea, József Tóvári, Miguel Tejeda, et al.Amino Acids|October 19, 2010
In vitro degradation and antitumor activity of oxime bond-linked daunorubicin-GnRH-III bioconjugates and DNA-binding properties of daunorubicin-amino acid metabolitesErika Orbán, Gábor Mezo, Pascal Schlage, et al.Bioconjugate Chemistry|March 11, 2009
Synthesis and antibody recognition of cyclic epitope peptides, together with their dimer and conjugated derivatives based on residues 9-22 of herpes simplex virus type 1 glycoprotein DAnnamária Jakab, Gitta Schlosser, Matty Feijlbrief, et al.Journal of Medicinal Chemistry|February 21, 2008
Antibody recognition and conformational flexibility of a plaque-specific beta-amyloid epitope modulated by non-native peptide flanking regionsMarilena Manea, Adrián Kalászi, Gábor Mezo, et al.Bioconjugate Chemistry|June 15, 2011
Enhanced enzymatic stability and antitumor activity of daunorubicin-GnRH-III bioconjugates modified in position 4Marilena Manea, Ulrike Leurs, Erika Orbán, et al.Pageof 6